Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
1.270
0.00 (0.00%)
Apr 25, 2025, 12:19 PM EDT - Market open
Akoya Biosciences Analyst Ratings
Total Analysts
7
Consensus Rating
Hold
Price Target
$2.99
Upside
+135.43%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $2.4 → $1.65 | Hold | Maintains | $2.4 → $1.65 | +29.92% | Apr 14, 2025 |
| Stephens & Co. | Stephens & Co. | Buy → Hold Downgrades $3.5 → $1.8 | Buy → Hold | Downgrades | $3.5 → $1.8 | +41.73% | Mar 25, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $3.5 | Buy | Reiterates | $3.5 | +175.59% | Mar 18, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $4 → $3 | Buy | Reiterates | $4 → $3 | +136.22% | Nov 19, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy → Hold Downgrades $7 → $5 | Strong Buy → Hold | Downgrades | $7 → $5 | +293.70% | Nov 15, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $6 → $3.5 | Strong Buy | Maintains | $6 → $3.5 | +175.59% | Nov 15, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $4 | Buy | Maintains | $6 → $4 | +214.96% | Aug 13, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $4 → $3 | Buy → Hold | Downgrades | $4 → $3 | +136.22% | Aug 6, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 6, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $7.5 → $7 | Strong Buy | Maintains | $7.5 → $7 | +451.18% | Aug 6, 2024 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 6, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $8 → $4 | Buy | Maintains | $8 → $4 | +214.96% | Jun 3, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 → $6 | Strong Buy | Maintains | $10 → $6 | +372.44% | May 14, 2024 |
| BTIG | BTIG | Strong Buy Maintains $9 → $6 | Strong Buy | Maintains | $9 → $6 | +372.44% | May 14, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +687.40% | Mar 6, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +687.40% | Mar 5, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.